Clinical genomics, read and reviewed for you
Every week, the most relevant publications in constitutional genetics, hereditary cancer, pharmacogenomics and bioinformatics — curated, scored against a public grid and reviewed by a medical biologist. Free, ad-free.
Every week, ~1,122 publications are screened down to a curated, scored selection — over 9,000 publications examined since launch.
This week on Geno'X
Four domains, one report per week each.
A GWAS study in 1086 pediatric patients treated with L-asparaginase for acute lymphoblastic leukemia identifies and replicates the rs149210846 variant as a genetic risk factor for severe (grade 3-4) L-asparaginase-induced pancreatitis. Carriers show 5.9- to 7.7-fold increased risk depending on pancreatitis grade. Risk is significantly higher in patients of Admixed-American (OR=8.8) and Asian (OR=10.0) genetic ancestry, highlighting the importance of genetic diversity in chemotherapy toxicity pharmacogenomics.
How it works
1. Exhaustive collection
Every week, PubMed, around a hundred specialty journals and bioRxiv/medRxiv preprints are screened across all 4 domains.
2. Transparent scoring
Each article is scored out of 10 against a public 5-criteria grid — clinical impact first. The score breakdown is shown on every article page.
3. Signed expert analysis
Every selected article is read and reviewed by a medical biologist: bilingual FR/EN summary and critical perspective — no black-box generated digest.
The full scoring grid is public: see the methodology.
Who is behind Geno'X?
Geno'X Veille is published by Dr Thibaut Benquey, a medical biologist specializing in constitutional genomics (WGS/WES) — from rare disease diagnosis to the clinical applications of next-generation sequencing. Every article is personally curated, scored and reviewed: no mass-generated content, no black box.
Follow on LinkedInWhy it's free
Geno'X Veille is a personal project — no ads, no sponsors, no sponsored content. No data is ever sold. The goal isn't commercial: it's to make clinical-genomics literature monitoring accessible to the whole community — biologists, geneticists, residents, genetic counsellors.
If you find the project useful, you can support hosting and curation time via Ko-fi — entirely optional.
Support on Ko-fiEvery Wednesday · Annotated selection · Free · Unsubscribe anytime